LEXARIA BIOSCIENCE CORP. Increase (Decrease) in Accounts Payable and Accrued Liabilities
LEXARIA BIOSCIENCE CORP. (LEXX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$1.11 million for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-05-31 was $167.77K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-02-28 was -$1.24M, a 181.55% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-11-30 was -$37.61K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-08-31 was $4.79K, a 99.49% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $396.64K, a 52.01% decline from fiscal 2024.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $826.47K, a 833.95% increase from fiscal 2023.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $88.49K, a 74.45% increase from fiscal 2022.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $50.73K, a 267.50% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 10 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2026-05-31 | $167.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | -$1.08M derived: sum of 2 quarters · filed 2026-07-13 | -$1.11M 10-Q · filed 2026-07-13 | -$1.11M derived: sum of 4 quarters · filed 2026-07-13 | ||
| 2026-02-28 | -$1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-13 | -$1.28M 10-Q · filed 2026-04-13 | -$1.28M derived: sum of 3 quarters · filed 2026-04-13 | -$1.61M derived: sum of 4 quarters · filed 2026-07-13 | ||
| 2025-11-30 | -$37.61K 10-Q · filed 2026-01-13 | -$32.83K derived: sum of 2 quarters · filed 2026-01-13 | -$367.64K derived: sum of 3 quarters · filed 2026-07-13 | $1.16M derived: sum of 4 quarters · filed 2026-07-13 | ||
| 2025-08-31 | $4.79K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | -$330.03K derived: sum of 2 quarters · filed 2026-07-13 | $1.19M derived: sum of 3 quarters · filed 2026-07-13 | $396.64K 10-K · filed 2025-11-28 | ||
| 2025-05-31 | -$334.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | $1.19M derived: sum of 2 quarters · filed 2026-07-13 | $391.85K 10-Q · filed 2026-07-13 | $1.33M derived: sum of 4 quarters · filed 2026-07-13 | ||
| 2025-02-28 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-13 | $726.67K 10-Q · filed 2026-04-13 | $1.66M derived: sum of 3 quarters · filed 2026-04-13 | $1.74M derived: sum of 4 quarters · filed 2026-04-13 | ||
| 2024-11-30 | -$797.42K 10-Q · filed 2026-01-13 | $140.20K derived: sum of 2 quarters · filed 2026-01-13 | $213.67K derived: sum of 3 quarters · filed 2026-01-13 | $170.02K derived: sum of 4 quarters · filed 2026-01-13 | ||
| 2024-08-31 | $937.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | $1.01M derived: sum of 2 quarters · filed 2025-11-28 | $967.44K derived: sum of 3 quarters · filed 2025-11-28 | $826.47K 10-K · filed 2025-11-28 | ||
| 2024-05-31 | $73.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-07-14 | $29.82K derived: sum of 2 quarters · filed 2025-07-14 | -$111.15K 10-Q · filed 2025-07-14 | -$894.80K derived: sum of 4 quarters · filed 2025-07-14 | ||
| 2024-02-29 | -$43.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-04-14 | -$184.62K 10-Q · filed 2025-04-14 | -$968.27K derived: sum of 3 quarters · filed 2025-04-14 | -$134.46K derived: sum of 4 quarters · filed 2025-04-14 | ||
| 2023-11-30 | -$140.97K 10-Q · filed 2025-01-10 | -$924.62K derived: sum of 2 quarters · filed 2025-01-10 | -$90.81K derived: sum of 3 quarters · filed 2025-01-10 | -$142.92K derived: sum of 4 quarters · filed 2025-01-10 | ||
| 2023-08-31 | -$783.65K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $50.16K derived: sum of 2 quarters · filed 2024-11-26 | -$1.95K derived: sum of 3 quarters · filed 2024-11-26 | $88.49K 10-K · filed 2024-11-26 | ||
| 2023-05-31 | $833.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | $781.70K derived: sum of 2 quarters · filed 2024-07-12 | $872.14K 10-Q · filed 2024-07-12 | $866.51K derived: sum of 4 quarters · filed 2024-07-12 | ||
| 2023-02-28 | -$52.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | $38.33K 10-Q · filed 2024-04-09 | $32.70K derived: sum of 3 quarters · filed 2024-04-09 | $73.19K derived: sum of 4 quarters · filed 2024-04-09 | ||
| 2022-11-30 | $90.44K 10-Q · filed 2024-01-12 | $84.82K derived: sum of 2 quarters · filed 2024-01-12 | $125.30K derived: sum of 3 quarters · filed 2024-01-12 | $52.35K derived: sum of 4 quarters · filed 2024-01-12 | ||
| 2022-08-31 | -$5.63K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | $34.86K derived: sum of 2 quarters · filed 2023-11-20 | -$38.09K derived: sum of 3 quarters · filed 2023-11-20 | $50.73K 10-K · filed 2023-11-20 | ||
| 2022-05-31 | $40.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | -$32.47K derived: sum of 2 quarters · filed 2023-07-14 | $56.35K 10-Q · filed 2023-07-14 | -$16.83K derived: sum of 4 quarters · filed 2023-07-14 | ||
| 2022-02-28 | -$72.95K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-04-14 | $15.87K 10-Q · filed 2023-04-14 | -$57.31K derived: sum of 3 quarters · filed 2023-04-14 | -$29.90K derived: sum of 4 quarters · filed 2023-04-14 | ||
| 2021-11-30 | $88.82K 10-Q/A · filed 2023-01-18 | $15.64K derived: sum of 2 quarters · filed 2023-01-18 | $43.05K derived: sum of 3 quarters · filed 2023-01-18 | $106.45K derived: sum of 4 quarters · filed 2023-01-18 | ||
| 2021-08-31 | -$73.18K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | -$45.77K derived: sum of 2 quarters · filed 2022-11-28 | $17.63K derived: sum of 3 quarters · filed 2022-11-28 | $13.80K 10-K · filed 2022-11-28 | ||
| 2021-05-31 | $27.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | $90.81K derived: sum of 2 quarters · filed 2022-07-14 | $86.98K 10-Q · filed 2022-07-14 | $118.77K derived: sum of 4 quarters · filed 2022-07-14 | ||
| 2021-02-28 | $63.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11 | $59.57K 10-Q · filed 2022-04-11 | $91.37K derived: sum of 3 quarters · filed 2022-04-11 | $84.80K derived: sum of 4 quarters · filed 2022-04-11 | ||
| 2020-11-30 | -$3.83K 10-Q · filed 2021-01-14 | $27.97K derived: sum of 2 quarters · filed 2021-11-29 | $21.41K derived: sum of 3 quarters · filed 2021-11-29 | -$9.93K derived: sum of 4 quarters · filed 2021-11-29 | ||
| 2020-08-31 | $31.79K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $25.23K derived: sum of 2 quarters · filed 2021-11-29 | -$6.11K derived: sum of 3 quarters · filed 2021-11-29 | -$49.49K 10-K · filed 2021-11-29 | ||
| 2020-05-31 | -$6.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15 | -$37.90K derived: sum of 2 quarters · filed 2021-07-15 | -$81.28K 10-Q · filed 2021-07-15 | -$56.17K derived: sum of 4 quarters · filed 2021-07-15 | ||
| 2020-02-29 | -$31.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | -$74.72K 10-Q · filed 2021-04-14 | -$49.61K derived: sum of 3 quarters · filed 2021-04-14 | -$432.77K derived: sum of 4 quarters · filed 2021-04-14 | ||
| 2019-11-30 | -$43.38K 10-Q · filed 2021-01-14 | -$18.27K derived: sum of 2 quarters · filed 2021-01-14 | -$401.43K derived: sum of 3 quarters · filed 2021-01-14 | -$15.26K derived: sum of 4 quarters · filed 2021-01-14 | ||
| 2019-08-31 | $25.11K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | -$358.05K derived: sum of 2 quarters · filed 2020-10-15 | $28.13K derived: sum of 3 quarters · filed 2020-10-15 | $100.63K 10-K · filed 2020-10-15 | ||
| 2019-05-31 | -$383.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | $3.01K derived: sum of 2 quarters · filed 2020-06-29 | $75.51K 10-Q · filed 2020-06-29 | $48.76K derived: sum of 4 quarters · filed 2020-06-29 | ||
| 2019-02-28 | $386.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | $458.67K 10-Q · filed 2020-04-03 | $431.92K derived: sum of 3 quarters · filed 2020-04-03 | $431.01K derived: sum of 4 quarters · filed 2020-04-03 | ||
| 2018-11-30 | $72.50K 10-Q · filed 2020-01-09 | $45.75K derived: sum of 2 quarters · filed 2020-01-09 | $44.84K derived: sum of 3 quarters · filed 2020-01-09 | $48.43K derived: sum of 4 quarters · filed 2020-01-09 | ||
| 2018-08-31 | -$26.75K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | -$27.66K derived: sum of 2 quarters · filed 2019-11-14 | -$24.07K derived: sum of 3 quarters · filed 2019-11-14 | $3.21K 10-K · filed 2019-11-14 | ||
| 2018-05-31 | -$914.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | $2.68K derived: sum of 2 quarters · filed 2019-07-08 | $29.96K 10-Q · filed 2019-07-08 | $49.58K derived: sum of 4 quarters · filed 2019-07-08 | ||
| 2018-02-28 | $3.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $30.87K 10-Q · filed 2019-04-15 | $50.49K derived: sum of 3 quarters · filed 2019-04-15 | $37.48K derived: sum of 4 quarters · filed 2019-04-15 | ||
| 2017-11-30 | $27.28K 10-Q · filed 2019-01-11 | $46.90K derived: sum of 2 quarters · filed 2019-01-11 | $33.89K derived: sum of 3 quarters · filed 2019-01-11 | -$14.05K derived: sum of 4 quarters · filed 2019-01-11 | ||
| 2017-08-31 | $19.62K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $6.61K derived: sum of 2 quarters · filed 2018-11-14 | -$41.33K derived: sum of 3 quarters · filed 2018-11-14 | -$40.44K 10-K · filed 2018-11-14 | ||
| 2017-05-31 | -$13.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | -$60.95K derived: sum of 2 quarters · filed 2018-07-13 | -$60.05K 10-Q · filed 2018-07-13 | -$270.71K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-02-28 | -$47.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | -$47.05K 10-Q · filed 2018-04-12 | -$257.70K derived: sum of 3 quarters · filed 2018-11-14 | |||
| 2016-11-30 | $898.00 10-Q · filed 2018-01-12 | -$209.76K derived: sum of 2 quarters · filed 2018-11-14 | ||||
| 2016-08-31 | -$210.66K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $56.94K 10-K · filed 2018-11-14 | ||||
| 2016-05-31 | $267.59K 10-Q · filed 2017-07-14 | |||||
| 2016-02-29 | $195.39K 10-Q · filed 2017-04-14 | |||||
| 2015-11-30 | $29.57K 10-Q · filed 2017-01-13 | $122.27K 10-Q · filed 2016-01-08 | $1.81K derived: sum of 2 quarters · filed 2017-01-13 | |||
| 2015-08-31 | -$27.76K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | -$60.48K 10-K · filed 2016-11-29 | ||||
| 2015-05-31 | -$32.72K 10-Q · filed 2016-07-13 | |||||
| 2015-02-28 | -$57.18K 10-Q · filed 2016-04-13 | |||||
| 2014-11-30 | $15.85K 10-Q · filed 2016-01-08 | $9.55K derived: sum of 2 quarters · filed 2016-01-08 | ||||
| 2014-08-31 | -$6.30K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | -$42.72K 10-KT · filed 2014-12-09 | -$42.72K 10-K · filed 2015-11-27 | |||
| 2014-07-31 | $13.61K 10-Q · filed 2014-11-14 | |||||
| 2014-05-31 | -$36.42K 10-Q · filed 2015-07-14 | |||||
| 2014-02-28 | $18.48K 10-Q · filed 2015-04-14 | |||||
| 2013-11-30 | $18.48K 10-Q · filed 2015-01-14 | |||||
| 2013-10-31 | $39.84K derived: 10-KT 12 month − 10-Q 9 month · filed 2014-12-09 | $69.23K 10-KT · filed 2014-12-09 | ||||
| 2013-08-31 | $18.48K 10-KT · filed 2014-12-09 | |||||
| 2013-07-31 | $29.39K 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |